Comparison

PI3K/Akt/mTOR-IN-2 European Partner

Manufacturer MedChem Express
Category
Type Inhibitors
Specific against other
Amount 5 mg
Item no. HY-146751-5mg
Targets PI3K, MTOR
CASRN 2757804-89-8
eClass 6.1 30220300
eClass 9.0 32160605
Available
Product Description
PI3K/Akt/mTOR-IN-2 is a PI3K/AKT/mTOR pathway inhibitor. PI3K/Akt/mTOR-IN-2 possess anti-cancer effects and selectivity against MDA-MB-231 cells with IC50 value of 2.29 μM. PI3K/Akt/mTOR-IN-2 can induce cancer cell cycle arrest and apoptosis[1].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
Cancer-Kinase/protease
MolecularWeight
285.29
Clinical_Information
No Development Reported
Manufacturers Research_Area
Cancer
Solubility
DMSO : ≥ 100 mg/mL
Pathway
Apoptosis; PI3K/Akt/mTOR
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close